TGS Q1 2024 Presentation and Webcast
April 24, 2024 01:00 ET
|
TGS ASA
OSLO, Norway (24 April 2024) - TGS will release its Q1 2024 results at approximately 07:00 CEST on 8 May 2024. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 CEST at...
Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance
April 24, 2024 01:00 ET
|
Ipsen Pharma
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. Q1 2024 Q1 2023 %...
Start of Day Message
April 24, 2024 01:00 ET
|
GlobeNewswire, Inc.
LONDON, 24 Apr. 2024 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
April 24, 2024 01:00 ET
|
Pharming Group N.V.
Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the...
Melexis Q1 2024 results – First quarter sales of 241.8 million EUR
April 24, 2024 01:00 ET
|
Melexis N.V.
Regulated information Intermediate declaration by the Board of Directors Ieper, Belgium - April 24th, 2024, 07.00 hrs CET Dear, Please find herewith the link to our most...
NaaS Technology and its Parent Company, NewLink, Join the Open Invention Network Community
April 24, 2024 01:00 ET
|
Open Invention Network
New energy asset operator NaaS is reinforcing its commitment to open source by joining Open Invention Network.
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
April 24, 2024 00:30 ET
|
Novartis Pharma AG
There is currently no evidence-based treatment for the smallest babies with malaria The CALINA study tested a new ratio and dose of Coartem® (artemether- lumefantrine) to account for metabolic...
Harju Elekter Group financial results, 1-3/2024
April 24, 2024 00:00 ET
|
AS Harju Elekter Group.
Commentary from the management Harju Elekter’s 2024 began with more modest results than in the year before. In the longer term, however, it was still a strong first quarter. Despite our efforts to...
LILLIUS Token (LLT) to Be Listed on Global Crypto Exchange Gate.io
April 23, 2024 23:53 ET
|
LILLIUS
Singapore, April 23, 2024 (GLOBE NEWSWIRE) -- LILLIUS, an AI sports challenge platform, announces that its token, LLT, will be initially listed on Gate.io, a global cryptocurrency exchange, on April...
SHOALS TECHNOLOGIES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Shoals Technologies Group, Inc. - SHLS
April 23, 2024 22:59 ET
|
Kahn Swick & Foti, LLC
NEW ORLEANS, April 23, 2024 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...